Thubrikar Aortic Valve
Manufacturing · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3801 Germantown Pike Ste 205, Collegevil...Website
www.tavi.usRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Thubrikar Aortic Valve
Thubrikar Aortic Valve specializes in the development of innovative cardiovascular devices, particularly the Optimum transcatheter aortic valve (TAV) and the Precision 2 delivery catheter. Their products are designed for durability and are currently in investigational stages, aimed at enhancing patient outcomes in aortic valve replacement procedures. The company targets healthcare professionals and institutions involved in cardiac care, showcasing their advancements at major medical conferences. Thubrikar Aortic Valve is committed to clinical research and the continuous improvement of their technologies.Explore more
Thubrikar Aortic Valve Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Thubrikar Aortic Valve your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Thubrikar Aortic Valve launches new products
Check if Thubrikar Aortic Valve has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Thubrikar Aortic Valve is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Thubrikar Aortic Valve recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Thubrikar Aortic Valve
Thubrikar Aortic Valve, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Thubrikar Aortic Valve has new funding data
Click to see if Thubrikar Aortic Valve had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Thubrikar Aortic Valve
Find 2 more new buyers
Compare Similar Companies to Thubrikar Aortic Valve
Compare insights from companies similar to Thubrikar Aortic Valve, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
1-10
Private
-
-
JS
Jessica StonePh. D. Psychologist and RPT-S (Registered Play Therapist-Supervisor)
Company Profile Activity
Activity Insights
Thubrikar Aortic Valve is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Thubrikar Aortic Valve is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Thubrikar Aortic Valve.
Thubrikar Aortic Valve Tech Stack
A closer look at the technologies used by Thubrikar Aortic Valve
See more technologies
Thubrikar Aortic Valve News & Media
Thubrikar Aortic Valve to Present Clinical Success of the Optimum TAVI System™ in 12 Patients at TCT 2024
COLLEGEVILLE, Pa.--(BUSINESS WIRE)-- #TAVI--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) using the Precision 2™ Delivery Catheter. These procedures demonstrated excellent performance of both the valve and delivery catheter, despite the anatomical challenges presented by the patients. Interventional Cardiologist and TAVI-1 CE Mark trial Principal Investigator, Dr. Jaroslaw Trebacz,Thubrikar Aortic Valve Announces Clinical Success of the New Precision 2™ Delivery Catheter
COLLEGEVILLE, Pa.--(BUSINESS WIRE)-- #TAVI--Thubrikar Aortic Valve, Inc. today announced successful results in the first two patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) using the new Precision 2™ Delivery Catheter. Interventional Cardiologist and TAVI-1 Study Principal Investigator, Jaroslaw Trebacz, MD, performed the procedures at the John Paul II Hospital in Krakow, Poland. “The first two implants with the 2nd-generation delivery catheter could not be easier oThubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2™ Delivery Catheter
COLLEGEVILLE, Pa.--(BUSINESS WIRE)-- #TAVI--Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ (Optimum TAVI System™). The authorization allows for an additional 15 patients to be treated with the Optimum TAV™ using the Company’s 2nd-generation delivery catheter, the Precision 2™ Catheter. The Precision 2 Catheter is engineered to provide operators withAortic Innovation on the Rise: Global TAVI Market to Reach $14.08 Billion by 2030, Growing at 13.7% CAGR
DUBLIN, Aug. 23, 2023 /PRNewswire/ -- The "Transcatheter Aortic Valve Implantation (TAVI) Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War" report has been added to ResearchAndMarkets.com's offering. The...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Thubrikar Aortic Valve
Sign Up For FreeTo access detailed company insights
Thubrikar Aortic Valve specializes in the development of innovative cardiovascular devices, particularly the Optimum transcatheter aortic valve (TAV) and the Precision 2 delivery catheter. Their products are designed for durability and are currently in investigational stages, aimed at enhancing patient outcomes in aortic valve replacement procedure... Read More
